LD-2 disclosure · 3rd Quarter - Report
CENCORA, INC.
via CENCORA, INC.
Client
- Name
- CENCORA, INC.
- Location
- District of Columbia · United States of America
Registrant
- Firm
- CENCORA, INC.
- Description
- Pharmaceutical Distributor
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
Advancing Emergency Preparedness through One Health Act. COVID-19 vaccine Distribution. Strengthening Americas Strategic National Stockpile Act. Essential Medicines Strategic Stockpile Act.
LobbyistsRITA E NORTON · BRADFORD TALLAMY · VIVIENNE STAFFORD MITCHELL · ASHLEY ROSE O'SULLIVAN
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Health & Human Services, Dept of (HHS)
Medicare/Medicaid
Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program and Health Care Enhancement Act. Most Favored Nation (MFN) policy. Medicare Sequester Relief Act (H.R. 1868). American Rescue Plan. The Bolstering Innovative Options to Save Immediately on Medicines (BIOSIM) Act (H.R. 2815).
LobbyistsRITA E NORTON · BRADFORD TALLAMY · VIVIENNE STAFFORD MITCHELL · ASHLEY ROSE O'SULLIVAN
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Health & Human Services, Dept of (HHS)